WuXi Biologics Receives Asia's CMO of 2017 from BioPharma Industry Awards
SHANGHAI, March 5, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that it had received Asia\'s CMO of 2017 at the 8th...
For more information, please visit
https://www.prnewswire.com/news-releases[...]industry-awards-300608684.html
